Related Experiment Video
Updated: Jul 6, 2026

06:09
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
A mouse model for tracking nigrostriatal dopamine neuron axon growth
Joaquim Vives1, Piriya Sasajala, Kuo Hsuan Chang
1Institute for Stem Cell Research, University of Edinburgh, Edinburgh EH9 3JQ, United Kingdom.
Summary
Researchers developed a Pitx3-tau-lacZ reporter mouse to visualize midbrain dopaminergic neurons. This tool aids in studying Parkinson
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- The midbrain dopaminergic system, including substantia nigra and ventral tegmental area neurons, is crucial for motor control.
- Loss of substantia nigra neurons causes Parkinson's disease, highlighting the need for research tools.
- Understanding dopaminergic neuron development is key to addressing neurodegenerative disorders.
Purpose of the Study:
- To create a novel reporter mouse line for visualizing midbrain dopaminergic axonal tracts.
- To establish a tool for identifying molecules that regulate dopaminergic neuritogenesis.
Main Methods:
- Generated a knock-in reporter mouse line using homologous recombination.
- Inserted the tau-lacZ fusion gene into the Pitx3 locus.
- Utilized beta-galactosidase enzyme reaction for visualization of dopaminergic tracts in situ and in vitro.
Main Results:
- Successfully visualized midbrain dopaminergic axonal tracts from substantia nigra and ventral tegmental area in Pitx3-tau-lacZ mice.
- Demonstrated the utility of the reporter line in phenotypically normal heterozygous mice.
- Confirmed the feasibility of visualizing tracts in both fresh brain tissue and organ cultures.
Conclusions:
- The Pitx3-tau-lacZ reporter mouse is a valuable tool for studying midbrain dopaminergic system development.
- This model facilitates in vivo and in vitro investigations of factors influencing dopaminergic neuritogenesis.
- Enables research into potential therapeutic targets for Parkinson's disease and related motor disorders.
